Document Detail


The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres.
MedLine Citation:
PMID:  17239946     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It is advantageous to incorporate controlled growth factor delivery into tissue engineering strategies. The objective of this study was to develop a three-dimensional (3D) porous tissue engineering scaffold with the capability of controlled releasing recombinant human bone morphogenetic protein-7 (rhBMP-7) for enhancement of bone regeneration. RhBMP-7 was first encapsulated into poly(lactic-co-glycolic acid) (PLGA) nanospheres (NS) with an average diameter of 300nm. Poly(l-lactic acid) (PLLA) scaffolds with interconnected macroporous and nano-fibrous architectures were prepared using a combined sugar sphere template leaching and phase separation technique. A post-seeding technique was then utilized to immobilize rhBMP-7 containing PLGA nanospheres onto prefabricated nano-fibrous PLLA scaffolds with well-maintained 3D structures. In vitro release kinetics indicated that nanosphere immobilized scaffold (NS-scaffold) could release rhBMP-7 in a temporally controlled manner, depending on the chemical and degradation properties of the NS which were immobilized onto the scaffold. In vivo, rhBMP-7 delivered from NS-scaffolds induced significant ectopic bone formation throughout the scaffold while passive adsorption of rhBMP-7 into the scaffold resulted in failure of bone induction due to either the loss of rhBMP-7 biological function or insufficient duration within the scaffold. We conclude that the interconnected macroporous architecture and the sustained, prolonged delivery of bioactive rhBMP-7 from NS immobilized nano-fibrous scaffolds actively induced new bone formation throughout the scaffold. The approach offers a new delivery method of BMPs and a novel scaffold design for bone regeneration.
Authors:
Guobao Wei; Qiming Jin; William V Giannobile; Peter X Ma
Related Documents :
8790726 - Synthesis, physicochemical and biological properties of poly-alpha-amino acids--the sim...
7678226 - The involvement of cd14 in stimulation of cytokine production by uronic acid polymers.
17199476 - Micromorphological analysis of dentinal structure after irradiation with nd:yag laser a...
1715886 - Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. e...
2500346 - Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism.
2966206 - Biochemical characterization of an fc gamma receptor purified from human neutrophils.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2007-01-08
Journal Detail:
Title:  Biomaterials     Volume:  28     ISSN:  0142-9612     ISO Abbreviation:  Biomaterials     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-02-09     Completed Date:  2007-05-22     Revised Date:  2010-12-03    
Medline Journal Info:
Nlm Unique ID:  8100316     Medline TA:  Biomaterials     Country:  England    
Other Details:
Languages:  eng     Pagination:  2087-96     Citation Subset:  IM    
Affiliation:
Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109-2209, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Morphogenetic Protein 7
Bone Morphogenetic Proteins / metabolism*
Humans
Kinetics
Microscopy, Electron, Scanning
Nanotubes*
Osteogenesis*
Recombinant Proteins / metabolism
Tissue Engineering
Transforming Growth Factor beta / metabolism*
Grant Support
ID/Acronym/Agency:
DE13397/DE/NIDCR NIH HHS; DE14755/DE/NIDCR NIH HHS; DE15384/DE/NIDCR NIH HHS; R01 DE013397-04/DE/NIDCR NIH HHS; R01 DE013397-05/DE/NIDCR NIH HHS; R01 DE015384-01/DE/NIDCR NIH HHS; R01 DE015384-02/DE/NIDCR NIH HHS; R01 DE015384-03/DE/NIDCR NIH HHS; R01 DE015384-04/DE/NIDCR NIH HHS; R21 DE014755-01A1/DE/NIDCR NIH HHS; R21 DE014755-02/DE/NIDCR NIH HHS
Chemical
Reg. No./Substance:
0/BMP7 protein, human; 0/Bone Morphogenetic Protein 7; 0/Bone Morphogenetic Proteins; 0/Recombinant Proteins; 0/Transforming Growth Factor beta
Comments/Corrections
Comment In:
Nanomedicine (Lond). 2007 Jun;2(3):385-90   [PMID:  17716183 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Using implant connectors to support clinical abrasion probes: a methodological study.
Next Document:  A fusion protein of hepatocyte growth factor for immobilization to collagen.